Conférences  >  Médecine & Soins de Santé  >  Maladies Infectieuses

event lab. GmbH

Die Tagung bietet neben spannenden Vorträgen zu aktuellen Themen der Kinder- und Jugendmedizin – von Infektiologie über Endokrinologie und Chirurgie bis hin zur Neuropädiatrie –, auch interaktive Workshops, wie etwa zu Reanimation und Notfällen, Sonografie/Echokardiografie, „handwerklichen“ Übungen sowie zur Pflege des Neugeborenen. Zudem fördert sie den Austausch zwischen Wissenschaftlern, Ärzten und Fachkräften aus aller Welt.

Tagungsbüro event lab. GmbH;     Tél.: [(0341) 30 88 84 77];     Email.: ndgkj@eventlab.org

Infektiologie, Endokrinologie, Chirurgie, Neuropädiatrie, Reanimation, Sonografie, Echokardiografie

Pédiatrie, Néonatalogie,    Endocrinologie

ESCEO & IOF

The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) is a joint Congress of the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) is dedicated to all aspects of osteoporosis and related bone diseases.

Tél.: [003287852652];     Email.: info@humacom.com

rheumatology, osteoporosis, osteoarthrtisis, orthopedics, endocrinology

Endocrinologie,    Orthopédie

C2P Forum

The World Congress on Vaccines Research and Development, scheduled for April 24-25, 2025, in Paris, France, is set to be a pivotal event in the field of immunology and vaccine science. This prestigious congress will bring together leading researchers, scientists, healthcare professionals, and industry experts from around the globe to discuss the latest advancements and innovations in vaccine research and development.

Tél.: [+1-864-386-8505];     Email.: vaccines@c2presearch.com

Vaccines for New and Emerging Diseases, Bacterial and Viral Vaccines, Vaccines Against Respiratory Diseases (Influenza/COVID), Cancer Vaccines and Immunotherapy, Vaccine Clinical Trials, Vaccines for Antibiotic-Resistant Bacteria, Immune Characterization, Vaccine Adjuvants, Vaccine Technology & Delivery Platforms, Vaccines Safety and Efficacy, Vaccines Manufacturing and Regulatory, Mucosal Vaccines, Pediatric Vaccines, Plant-derived Vaccines, Veterinary Vaccines, Advances in DNA Vaccines, Conjugate Vaccines, HPV Vaccines, Vaccines against STIs, Recombinant Vaccines, Approaches for Vaccine Development, Bioprocessing and Manufacturing, Vaccine Hesitancy and Public Health Communication, One health approach to Vaccines

Immunologie et Allergie,    Génie biomédical

Join us for the European Public Health and Epidemiology Conference on April 28-29, 2025, in Lisbon, Portugal. This enlightening event will feature a panel of distinguished experts in public health and epidemiology. It's a prime opportunity to explore interconnected research fields and learn from industry leaders in the field. We look forward to welcoming you and fostering knowledge exchange and collaboration at this prestigious gathering.

Our esteemed speakers offer vast expertise in global health initiatives and pioneering research in public health and epidemiology. Seize this opportunity to enhance your understanding of One Health and its pivotal role in securing our future.

Tél.: [+1-864-386-8505];     Email.: publichealth@c2presearch.org

Public Health Conferences 2025, Upcoming Public Health Conferences 2025, Epidemiology Conferences 2025, Public Health and Epidemiology Conferences 2025, European Public Health and Epidemiology Conference 2025, Global Health Conferences 2025, Medical Conferences 2025, Top Public Health Conferences, Public Health Meetings 2025.

Harvard Medical School

State-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases--This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses—ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases; Newer antimicrobials and treatment strategies for highly resistant infections; Prevention and treatment of infection in immunocompromised hosts; Update on antifungal diagnostics and therapy; State-of-the-art and multidisciplinary approaches to common infections; Clinical approaches to complex, rare, and "don't-miss" infections; New, evolving, emerging, and re-emerging infectious diseases; Infections in persons with substance use disorder; What’s new in HIV prevention and management; The latest on COVID-19, including long COVID. As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Harvard Medical School Postgraduate Medical Education;     Email.: CEPrograms@hms.harvard.edu

Harvard, infection, CME, immunocompromised, antifungal, HIV, resistant infection, antimicrobial stewardship, substance use disorder, emerging infectious diseases, zoonoses, tick-borne, ENT, Vaccine, Vaccination, sexually transmitted infections, Hepatitis, MRSA, OPAT, COVID, STIs, difficile, C-diff, staph, PEP, PrEP, CNS, skin, soft tissue, avian flu, Marburg virus, Polio, Bronchiectasis, pneumonia, non-tuberculous mycobacteria

EMBL Heidelberg

Infectious diseases are among the most prevalent causes of human illness and death in the world. Epidemics & pandemics have shaped human evolution and history, and although for a while there were considered a solved problem for the developed world, the recent past has showed us all why this is not the case. Antimicrobial resistance, global warming, human population size increase, modern lifestyles (urbanization, traveling), decrease of wild-life habitats for pathogen reservoirs all contribute to creating an ideal setting for infectious diseases becoming an even greater challenge in the future. This symposium will bring together experts working on different pathogens (viruses, bacteria, fungi and parasites) and who rarely meet. It will cover a broad range of topics on the host-pathogen interface, highlighting the diversity in mechanisms and the convergence of strategies pathogens use to invade, hijack host machineries, proliferate within the host, cause disease and spread to other hosts. Infection biologists using systems biology, population genomics, genetics, cell and tissue biology, biochemistry and structural biology will meet to present the state-of-the-art of different fields. The emerging realisation that infections are often polymicrobial, pathogens can be opportunistic and can already reside for years as benign in our body, and that the microbiome can greatly impact infection onset and progress will provide a common thread of discussion across fields of different pathogenic agents. Discussions will fertilise transfer of technologies and know-how across fields, and set the ground for developing new strategies to tackle current bottlenecks in our ability to treat infections.

Catherine Casas-Saavedra;     Email.: catherine.casas@embl.de

Magnus Group

Join us for the 8th Edition of the World Congress on Infectious Diseases (Infection 2025) in Rome, Italy, from June 9-11, 2025. This hybrid Infectious Diseases Conferences 2025, with the theme "Global Challenges, Local Impacts: Innovations in Infectious Disease Prevention, Diagnosis, and Treatment," offers a vital platform for professionals in the field. Attend engaging keynote sessions, participate in interactive workshops, and connect with global experts both in-person and online. This is your opportunity to share cutting-edge research, collaborate on new strategies, and contribute to advancements in the fight against infectious diseases

Tél.: [1 (702) 988 2320];     Email.: infectious@magnusconference.com

Infectious Diseases Conferences 2025, Infection Conferences 2025, Infection Conference 2025, Infection Conferences, Infection Congress 2025, Infection Event 2025, International Infection Congress 2025, Global Infectious Diseases Congress 2025, Infectious Diseases Symposium 2025, Infection and Disease Conference 2025, Infectious Disease Forum 2025, Infection Science Conference 2025, Clinical Infectious Diseases Congress 2025, Infection Prevention Conference 2025, Emerging Infectious Diseases Congress 2025, Infectious Diseases Summit 2025, Infection Research Conference 2025, Infectious Disease Innovation Forum 2025, Global Infection Symposium 2025, Infectious Diseases Workshop 2025, Infection Management Conference 2025, Infectious Diseases Expo 2025, International Infectious Diseases Summit 2025, Infection Control Congress 2025, Infectious Diseases & Public Health Conference 2025, Infection Trends Symposium 2025, World Congress on Infectious Diseases 2025

Iris Scientific Group is excited to announce the upcoming "Infectious Diseases Congress 2025 (IDC 2025)", set against the backdrop of Paris, a dynamic hub of innovation and culture. Scheduled from June 19-20, 2025, this conference promises an engaging and enlightening experience for attendees and contributors alike. Recognizing the evolving global landscape, IDC 2025 is designed as a Hybrid Event, allowing participants to engage either in-person at Paris, France or Virtually, ensuring accessibility to a worldwide audience. The conference theme, "Harnessing Digital Health: Innovations in Infectious Disease Surveillance and Management," underscores our commitment to exploring transformative digital technologies in disease prevention and control.

Rapid Point of Care Research Consortium for Infectious Diseases (RAPID) and ASHM Health

EMBL Heidelberg

Human microbiota – the collection of microbes living in and on our body – have a significant impact on human health and well-being. They have been associated with numerous diseases, yet we are still far from understanding their role in the context of lifestyle and genetics. Various initiatives are underway around the world to survey the human microbiota at several body sites, characterise them, understand their interactions with the human hosts, elucidate their role in diseases, and design possible therapeutic or dietary interventions. There is a new wave of studies mining the human microbiota for health-relevant bioactive compounds, for characterising specific microbial strains and for cataloguing the human microbiota from all across the globe. This conference will provide plentiful opportunities for researchers to learn about and to connect to important developments in studying the human microbiota.

EMBL Events;     Email.: events@embl.de

Meningitis Research Foundation

We are delighted to announce that we will be holding our 15th International Meningitis Research Foundation Conference on the 18th-19th November 2025, at the BMA House in London, UK Our world-leading research conference, dedicated to meningitis, invites delegates from around the world to join us for two days of cutting-edge presentations, panel discussions and poster presentations; as well as the opportunity to network.

Senior Research and Events Officer;     Tél.: [+44 333 405 6278];     Email.: mariuszk@meningitis.org

Infectious diseases, meningitis, paediatrics, academic, public health, microbiology, biology, epidemiology, genetics, medicine, healthcare, research, vaccinology

Médecine (en général), médecine interne,    Épidémiologie